{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:11:31Z","timestamp":1789560691634,"version":"build-2803163510"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":5,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To evaluate whether opportunistic atrial fibrillation (AF) screening in adults aged\u2009\u2265\u200965 years improves AF detection and clinical outcomes compared with usual care, and to compare opportunistic and systematic screening strategies in terms of AF detection and clinical outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic review was conducted in accordance with PRISMA 2020 guidelines. Randomized and cluster-randomized controlled trials evaluating opportunistic or systematic AF screening in adults aged\u2009\u2265\u200965 years were included. Electronic databases (MEDLINE, Embase, and CENTRAL) were searched from inception to December 2024.<\/jats:p>\n                    <jats:p>Studies with sufficiently comparable outcome data were included in a structured descriptive quantitative synthesis of AF detection rates. Because of substantial clinical and methodological heterogeneity among the included studies, a pooled meta-analysis was not performed. Instead, study-level outcomes were summarized descriptively. Studies with heterogeneous designs or outcome reporting were synthesized narratively. Outcomes of interest included AF detection, initiation of oral anticoagulation, stroke incidence, and all-cause mortality. Risk of bias was assessed using the Cochrane Risk of Bias 2.0 tool. Study selection and data extraction were performed independently by two reviewers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Nine randomized or cluster-randomized trials were included. Both opportunistic and systematic screening approaches were associated with increased detection of previously undiagnosed AF compared with usual care.<\/jats:p>\n                    <jats:p>Opportunistic screening increased AF detection in several trials; however, direct comparisons with systematic approaches should be interpreted cautiously because of heterogeneity in monitoring intensity, follow-up duration, and population characteristics.<\/jats:p>\n                    <jats:p>Studies employing prolonged or continuous monitoring generally yielded higher AF detection rates; however, direct comparisons with opportunistic screening should be interpreted cautiously because of differences in monitoring intensity, follow-up duration, and population characteristics. Anticoagulation initiation varied across studies. Across studies, no consistent reduction in stroke incidence or all-cause mortality was observed. Most trials were judged to have some concerns regarding risk of bias, primarily related to pragmatic trial designs. Because AF diagnosis was confirmed using objective electrocardiographic criteria, the risk of outcome measurement bias was generally low.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>AF screening increases detection of previously undiagnosed AF in older adults. Opportunistic screening may be more readily integrated into routine healthcare encounters than organized systematic screening programs; however, implementation outcomes and cost-effectiveness were not consistently evaluated across the included trials. Current randomized evidence does not demonstrate consistent improvement in clinical outcomes such as stroke reduction or mortality, highlighting the need for further high-quality randomized trials evaluating integrated screening and post-detection care pathways.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12872-026-06253-2","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T23:34:21Z","timestamp":1789083261000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Opportunistic and systematic screening for atrial fibrillation in adults aged\u2009\u2265\u200965 years in primary care: a systematic review of randomized and cluster randomized trials"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-7847-8530","authenticated-orcid":false,"given":"Mohamed Ali","family":"Mansour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Ezzat Ibrahim","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Shawky Al-Didamony Tantawy","family":"Foda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"key":"6253_CR1","doi-asserted-by":"publisher","first-page":"CD009586","DOI":"10.1002\/14651858.CD009586.pub3","volume":"6","author":"PS Moran","year":"2016","unstructured":"Moran PS, Teljeur C, Ryan M, Smith SM. Systematic screening for the detection of atrial fibrillation. Cochrane Database Syst Rev. 2016;6:CD009586. https:\/\/doi.org\/10.1002\/14651858.CD009586.pub3.","journal-title":"Cochrane Database Syst Rev"},{"issue":"19","key":"6253_CR2","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1161\/CIRCULATIONAHA.116.026693","volume":"135","author":"B Freedman","year":"2017","unstructured":"Freedman B, Camm J, Calkins H, Healey JS, Rosenqvist M, Wang J, et al. Screening for atrial fibrillation: a report of the AF-SCREEN International Collaboration. Circulation. 2017;135(19):1851\u201367. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.026693.","journal-title":"Circulation"},{"issue":"5","key":"6253_CR3","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2021","unstructured":"Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstr\u00f6m-Lundqvist C, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation. Eur Heart J. 2021;42(5):373\u2013498. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa612.","journal-title":"Eur Heart J"},{"issue":"4","key":"6253_CR4","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1001\/jama.2021.23732","volume":"327","author":"KW Davidson","year":"2022","unstructured":"US Preventive Services Task Force, Davidson KW, Barry MJ, Mangione CM, Cabana M, Caughey AB, et al. Screening for atrial fibrillation: US Preventive Services Task Force recommendation statement. JAMA. 2022;327(4):360\u20137. https:\/\/doi.org\/10.1001\/jama.2021.23732.","journal-title":"JAMA"},{"key":"6253_CR5","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"BMJ"},{"issue":"40","key":"6253_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta9400","volume":"9","author":"FDR Hobbs","year":"2005","unstructured":"Hobbs FDR, Fitzmaurice DA, Mant J, Murray E, Jowett S, Bryan S, et al. A randomised controlled trial and cost-effectiveness study of systematic screening versus routine practice for the detection of atrial fibrillation in people aged\u2009\u2265\u200965 years (SAFE study). Health Technol Assess. 2005;9(40):1\u201374. https:\/\/doi.org\/10.3310\/hta9400.","journal-title":"Health Technol Assess"},{"issue":"7616","key":"6253_CR7","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1136\/bmj.39280.660567.55","volume":"335","author":"DA Fitzmaurice","year":"2007","unstructured":"Fitzmaurice DA, Hobbs FDR, Jowett S, Mant J, Murray ET, Holder R, et al. Screening versus routine practice in detection of atrial fibrillation in patients aged\u2009\u2265\u200965 years: cluster randomised controlled trial. BMJ. 2007;335(7616):383. https:\/\/doi.org\/10.1136\/bmj.39280.660567.55.","journal-title":"BMJ"},{"issue":"25","key":"6253_CR8","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1161\/CIRCULATIONAHA.114.014343","volume":"131","author":"E Svennberg","year":"2015","unstructured":"Svennberg E, Engdahl J, Al-Khalili F, Friberg L, Frykman V, Rosenqvist M. Mass screening for untreated atrial fibrillation: the STROKESTOP study. Circulation. 2015;131(25):2176\u201384. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.114.014343.","journal-title":"Circulation"},{"issue":"10310","key":"6253_CR9","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1016\/S0140-6736(21)01698-6","volume":"398","author":"JH Svendsen","year":"2021","unstructured":"Svendsen JH, Diederichsen SZ, H\u00f8jberg S, Krieger DW, Graff C, Kronborg C, et al. Implantable loop recorder detection of atrial fibrillation to prevent stroke (LOOP study): a randomised controlled trial. Lancet. 2021;398(10310):1507\u201316. https:\/\/doi.org\/10.1016\/S0140-6736(21)01698-6.","journal-title":"Lancet"},{"issue":"19","key":"6253_CR10","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1161\/CIRCULATIONAHA.117.030583","volume":"136","author":"JPJ Halcox","year":"2017","unstructured":"Halcox JPJ, Wareham K, Cardew A, Gilmore M, Barry JP, Phillips C, et al. Assessment of remote heart rhythm sampling using the AliveCor heart monitor to screen for atrial fibrillation: the REHEARSE-AF study. Circulation. 2017;136(19):1784\u201394. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.030583.","journal-title":"Circulation"},{"issue":"5","key":"6253_CR11","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1001\/jamacardio.2021.0038","volume":"6","author":"DJ Gladstone","year":"2021","unstructured":"Gladstone DJ, Wachter R, Schmalstieg-Bahr K, Quinn FR, Hummers E, Ivers N, et al. Screening for atrial fibrillation in the older population: a randomized clinical trial (SCREEN-AF). JAMA Cardiol. 2021;6(5):558\u201367. https:\/\/doi.org\/10.1001\/jamacardio.2021.0038.","journal-title":"JAMA Cardiol"},{"key":"6253_CR12","doi-asserted-by":"publisher","first-page":"m3208","DOI":"10.1136\/bmj.m3208","volume":"370","author":"SB Uittenbogaart","year":"2020","unstructured":"Uittenbogaart SB, Verbiest-van Gurp N, Lucassen WAM, Winkens B, Nielen M, Erkens PMG, et al. Opportunistic screening versus usual care for detection of atrial fibrillation in primary care: cluster randomised controlled trial. BMJ. 2020;370:m3208. https:\/\/doi.org\/10.1136\/bmj.m3208.","journal-title":"BMJ"},{"issue":"13","key":"6253_CR13","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1161\/CIRCULATIONAHA.121.057014","volume":"145","author":"SA Lubitz","year":"2022","unstructured":"Lubitz SA, Atlas SJ, Ashburner JM, Lipsanopoulos ATT, Borowsky LH, Guan W, et al. Screening for atrial fibrillation in older adults at primary care visits: the VITAL-AF randomized controlled trial. Circulation. 2022;145(13):946\u201354. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.121.057014.","journal-title":"Circulation"},{"issue":"2","key":"6253_CR14","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1001\/jama.2018.8102","volume":"320","author":"SR Steinhubl","year":"2018","unstructured":"Steinhubl SR, Waalen J, Edwards AM, Mehta RR, Ebner GS, Carter C, et al. Effect of a home-based wearable continuous ECG monitoring patch on detection of undiagnosed atrial fibrillation: the mSToPS randomized clinical trial. JAMA. 2018;320(2):146\u201355. https:\/\/doi.org\/10.1001\/jama.2018.8102.","journal-title":"JAMA"},{"key":"6253_CR15","doi-asserted-by":"publisher","first-page":"101598","DOI":"10.1016\/j.ijcha.2025.101598","volume":"56","author":"M Yildirim","year":"2025","unstructured":"Yildirim M, Hund H, Mueller-Hennessen M, Katus HA, Frey N, Giannitsis E, Salbach C. Clinical impact of inappropriate DOAC dosing in atrial fibrillation: Insights from a real-world registry. Int J Cardiol Heart Vasc. 2025;56:101598. https:\/\/doi.org\/10.1016\/j.ijcha.2025.101598.","journal-title":"Int J Cardiol Heart Vasc"},{"issue":"4","key":"6253_CR16","doi-asserted-by":"publisher","first-page":"e036832","DOI":"10.1161\/JAHA.124.036832","volume":"14","author":"M Yildirim","year":"2025","unstructured":"Yildirim M, Milles BR, Hund H, Biener M, M\u00fcller-Hennessen M, Frey N, Katus HA, Giannitsis E, Salbach C. Outcomes and Disease Management in Patients With Atrial Fibrillation\u2009\u2265\u200980 Years: Data From a Consecutive 11-Year Real-World Registry. J Am Heart Assoc. 2025;14(4):e036832. https:\/\/doi.org\/10.1161\/JAHA.124.036832.","journal-title":"J Am Heart Assoc"},{"issue":"8","key":"6253_CR17","doi-asserted-by":"publisher","first-page":"e0330164","DOI":"10.1371\/journal.pone.0330164","volume":"20","author":"C Salbach","year":"2025","unstructured":"Salbach C, Yildirim M, Milles BR, Hund H, Mueller-Hennessen M, Frey N, Katus H, Giannitsis E. Improvement in risk prediction for patients with atrial fibrillation and intermediate-risk CHA\u2082DS\u2082-VASc score utilizing highly sensitive cardiac troponin T. PLoS ONE. 2025;20(8):e0330164. https:\/\/doi.org\/10.1371\/journal.pone.0330164.","journal-title":"PLoS ONE"},{"issue":"12","key":"6253_CR18","doi-asserted-by":"publisher","first-page":"euaf229","DOI":"10.1093\/europace\/euaf229","volume":"27","author":"AG Rigutini","year":"2025","unstructured":"Rigutini AG, Bucci T, Rossi M, Tartaglia E, Askarinejad A, Romiti GF, Becattini C, Boriani G, Tse HF, Chao TF, Lip GYH. Clinical complexity in patients with atrial fibrillation: exploring differential risk profiles from European and Asian cohorts. Europace. 2025;27(12):euaf229. https:\/\/doi.org\/10.1093\/europace\/euaf229.","journal-title":"Europace"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-06253-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06253-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06253-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:56:47Z","timestamp":1789559807000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12872-026-06253-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6253"],"URL":"https:\/\/doi.org\/10.1186\/s12872-026-06253-2","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]},"assertion":[{"value":"8 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"805"}}